| Rofecoxib | Approved Withdrawn | FAIM2 | 23017 |
downregulated | rofecoxib results in decreased expression of FAIM2 mRNA | 12q13.12 | |
| Rofecoxib | Approved Withdrawn | FLNB | 2317 |
upregulated | rofecoxib results in increased expression of FLNB mRNA | 3p14.3 | |
| Rofecoxib | Approved Withdrawn | FOXD1 | 2297 |
downregulated | rofecoxib results in decreased expression of FOXD1 mRNA | 5q13.2 | |
| Rofecoxib | Approved Withdrawn | GATA3 | 2625 |
downregulated | rofecoxib results in decreased expression of GATA3 mRNA | 10p14 | |
| Rofecoxib | Approved Withdrawn | HGF | 3082 |
downregulated | rofecoxib results in decreased expression of HGF mRNA | 7q21.11 | |
| Rofecoxib | Approved Withdrawn | HPGD | 3248 |
downregulated | rofecoxib results in decreased expression of HPGD mRNA | 4q34.1 | |
| Rofecoxib | Approved Withdrawn | IL1RN | 3557 |
upregulated | rofecoxib results in increased expression of IL1RN mRNA | 2q14.1 | |
| Rofecoxib | Approved Withdrawn | IL6 | 3569 |
upregulated | rofecoxib results in increased expression of IL6 mRNA | 7p15.3 | |
| Rofecoxib | Approved Withdrawn | INSM1 | 3642 |
downregulated | rofecoxib results in decreased expression of INSM1 mRNA | 20p11.23 | |
| Rofecoxib | Approved Withdrawn | LIFR | 3977 |
downregulated | rofecoxib results in decreased expression of LIFR mRNA | 5p13.1 | |
| Rofecoxib | Approved Withdrawn | LMX1A | 4009 |
upregulated | rofecoxib results in increased expression of LMX1A mRNA | 1q23.3 | |
| Rofecoxib | Approved Withdrawn | MAL | 4118 |
upregulated | rofecoxib results in increased expression of MAL mRNA | 2q11.1 | |
| Rofecoxib | Approved Withdrawn | MAPRE2 | 10982 |
downregulated | rofecoxib results in decreased expression of MAPRE2 mRNA | 18q12.1-q12.2 | |
| Rofecoxib | Approved Withdrawn | MBTD1 | 54799 |
downregulated | rofecoxib results in decreased expression of MBTD1 mRNA | 17q21.33 | |
| Rofecoxib | Approved Withdrawn | MEOX2 | 4223 |
downregulated | rofecoxib results in decreased expression of MEOX2 mRNA | 7p21.2 | |
| Rofecoxib | Approved Withdrawn | MMP1 | 4312 |
upregulated | rofecoxib results in increased expression of MMP1 mRNA | 11q22.2 | |
| Rofecoxib | Approved Withdrawn | MMP3 | 4314 |
upregulated | rofecoxib results in increased expression of MMP3 mRNA | 11q22.2 | |
| Rofecoxib | Approved Withdrawn | MTA2 | 9219 |
downregulated | rofecoxib results in decreased expression of MTA2 mRNA | 11q12.3 | |
| Rofecoxib | Approved Withdrawn | NAALADL2 | 254827 |
downregulated | rofecoxib results in decreased expression of NAALADL2 mRNA | 3q26.31 | |
| Rofecoxib | Approved Withdrawn | NFASC | 23114 |
downregulated | rofecoxib results in decreased expression of NFASC mRNA | 1q32.1 | |
| Rofecoxib | Approved Withdrawn | NPAS3 | 64067 |
upregulated | rofecoxib results in increased expression of NPAS3 mRNA | 14q13.1 | |
| Rofecoxib | Approved Withdrawn | NPR2 | 4882 |
downregulated | rofecoxib results in decreased expression of NPR2 mRNA | 9p13.3 | |
| Rofecoxib | Approved Withdrawn | PI4KA | 5297 |
downregulated | rofecoxib results in decreased expression of PI4KA mRNA | 22q11.21 | |
| Rofecoxib | Approved Withdrawn | PLAT | 5327 |
upregulated | rofecoxib results in increased expression of PLAT mRNA | 8p11.21 | |
| Rofecoxib | Approved Withdrawn | PML | 5371 |
upregulated | rofecoxib results in increased expression of PML mRNA | 15q24.1 | |